They are limitations and concerns drawn from the published scientific record and the consumer-marketplace literature
(Related reading: the underlying reality of workplace lookism .) [Trigger warning: ED content.] The WSJ ran two GLP-1 stories 12 days apart, illustrating the paradox with these drugs: one on how the drugs may activate dormant eating disorders, the other on emerging evidence they help people recover from them
As always I had the most incredible facial with Juliet
More patients receiving semaglutide discontinued treatment due to GI adverse reactions than patients receiving placebo during all clinical trials
We detail what must be known about BPC-157, including data from cutting-edge, peer-reviewed studies and how to successfully incorporate this popular peptide into research on erectile dysfunction
doi: 10.1523/ENEURO.0268-20.2020 [DOI] [PMC free article] [PubMed] [Google Scholar] 47.van de Giessen E, de Bruin K, la Fleur SE, van den Brink W, Booij J